| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.09 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.097 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |